Jove
Visualize
Contact Us

Related Experiment Videos

Corticosteroids for septic shock.

D Annane1

  • 1Service de Réanimation Médicale, Hôpital Raymond Poincaré, Faculté de Médecine Paris-Ouest, University Paris V, Garches, France. djillali.annane@rpc.ap-hop-paris.fr

Critical Care Medicine
|July 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous DNAJB4 deletion revealing myopathy with acute respiratory failure.

Revue neurologique·2025
Same author

Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study.

Revue neurologique·2022
Same author

Perioperative fluid management for major elective surgery.

The British journal of surgery·2020
Same author

Mismatch negativity to predict subsequent awakening in deeply sedated critically ill patients.

British journal of anaesthesia·2018
Same author

Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.

Spinal cord·2016
Same author

Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study.

Spinal cord·2016
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hydrocortisone replacement therapy is recommended for patients with septic shock. This treatment may improve symptoms, shorten shock duration, and increase survival rates in severe sepsis.

Area of Science:

  • Critical Care Medicine
  • Endocrinology
  • Pharmacology

Background:

  • Corticosteroids were initially tested for septic patients, but high-dose, short-term use proved ineffective and harmful.
  • Altered hypothalamic-pituitary-adrenal axis function in septic shock necessitates re-evaluating corticosteroid use.
  • Septic shock involves a complex inflammatory response and potential adrenal insufficiency.

Purpose of the Study:

  • To provide evidence supporting hydrocortisone replacement therapy in septic shock.
  • To analyze the efficacy and safety of corticosteroids in severe sepsis and septic shock.
  • To establish a rationale for using hydrocortisone in catecholamine-dependent septic shock.

Main Methods:

  • Systematic review of randomized trials and animal studies from Medline and Cochrane Library.

Related Experiment Videos

  • Inclusion of studies detailing corticosteroid mechanisms of action or use in severe sepsis.
  • Focus on human studies with significant data on corticosteroid efficacy.

    • Main Results:

    • Randomized trials indicate high-dose steroids are ineffective and potentially harmful in severe sepsis.
    • Replacement therapy with hydrocortisone in catecholamine-dependent septic shock shows promise.
    • Hydrocortisone may alleviate systemic inflammatory response symptoms and reduce shock duration.

    Conclusions:

    • Low-dose hydrocortisone replacement therapy is suggested for catecholamine-dependent septic shock.
    • Evidence supports increasing therapeutic interest in corticosteroid replacement therapy for septic shock.
    • Further research may refine hydrocortisone dosing and indications in septic shock management.